COMP <GO>
XPO vs PG // RETURN ON INVESTED CAPITAL (ROIC)
XPO Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: XPO 2
— PG 12
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PG
LAST: $189.57 (+3.58%) • MKT CAP: $21.43B
roic
10.80%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
roic
25.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XPO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XPO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 10.80% | 25.40% | -14.60 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.1x | 16.2x | +3.90 | PG | /valuation <GO> |
| Free Cash Flow Yield | -1.38% | 3.77% | -5.15 | PG | /fcf-yield <GO> |
| Operating Margin | 8.00% | 24.30% | -16.30 | PG | /operating-margins <GO> |
| Net Profit Margin | 3.90% | 19.00% | -15.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 0.30% | +0.80 | XPO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.69 | 5.59 | -0.90 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.50% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.4 | 62.7 | -6.33 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.87 | +0.02 | XPO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 63.1x | 21.7x | +41.40 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.43B | $372.21B | -$350.78B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XPO REV | PG REV | XPO GROSS % | PG GROSS % | XPO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.16B | $84.28B | 44.0% | 51.2% | -$303.1M | $14.04B |
| FY 2024 | $8.07B | $84.04B | 44.0% | 51.4% | -$355.6M | $16.52B |
| FY 2023 | $7.74B | $82.01B | 44.0% | 44.0% | -$136.8M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XPO // BETA 0.89
PG // BETA 0.87